J. Casey McGlynn formed the Life Sciences Group at Wilson Sonsini Goodrich & Rosati in 1990.  It is a nationally recognized practice representing startups and emerging growth companies in the life sciences field–Medical Devices, Digital Health, Diagnostics and Biotechnology. Mr. McGlynn has formed, sold and taken public many of the most important medical device companies formed during the last 30 years. Mr. McGlynn has extensive hands-on experience in helping entrepreneurs form, build, fund and sell their companies.  He has built close working relationships with an unparalleled list of entrepreneurs, doctors, investors, engineers and managers in the life sciences field.  Through his portfolio of companies he has met and negotiated with the leaders of all of the major Medtech acquirers. Mr. McGlynn was a founding member of BIO and served on the Emerging Company Board of BIO for over a decade.  Mr. McGlynn currently serves on the Medical Device Manufacturers Association, a Washington trade organization focused on issues of importance to the biomedical industry.  Mr. McGlynn is also a founder and director of Life Science Angels.  Since 2005 LSA has invested over $40 million in more than 50 life science companies that have received in excess of $500 million of follow-on funding.  Mr McGlynn is a frequent speaker at biomedical industry events.